Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

The Use of Samples Originating From Doping Control Procedures for Research Purposes: A Qualitative Study.

Devriendt T, Phillips A, Shabani M, Borry P.

J Empir Res Hum Res Ethics. 2019 Jul;14(3):254-261. doi: 10.1177/1556264619842782. Epub 2019 May 22.

PMID:
31113287
2.

Consent insufficient for data release.

Nicol D, Eckstein L, Bentzen HB, Borry P, Burgess M, Burke W, Chalmers D, Cho M, Dove E, Fullerton S, Ida R, Kato K, Kaye J, Koenig B, Manson S, McGrail K, Meslin E, O'Doherty K, Prainsack B, Shabani M, Tabor H, Thorogood A, de Vries J.

Science. 2019 May 3;364(6439):445-446. doi: 10.1126/science.aax0892. No abstract available.

PMID:
31048483
3.

Reproductive autonomy in expanded carrier screening: more than meets the eye?

Chokoshvili D, Vears DF, Borry P.

Expert Rev Mol Diagn. 2018 Nov 5:1-2. doi: 10.1080/14737159.2018.1544496. [Epub ahead of print] No abstract available.

PMID:
30394810
4.

Variant data sharing by clinical laboratories through public databases: consent, privacy and further contact for research policies.

Shabani M, Dyke SOM, Marelli L, Borry P.

Genet Med. 2019 May;21(5):1031-1037. doi: 10.1038/s41436-018-0316-x. Epub 2018 Oct 8.

PMID:
30293992
5.

Renal Replacement Therapy in children with severe developmental disability: guiding questions for decision-making.

Willem L, Knops N, Mekahli D, Cochat P, Edefonti A, Verrina E, Groothoff J, Lagae L, Pirenne J, Dobbels F, Borry P, Van Geet C, Levtchenko E.

Eur J Pediatr. 2018 Dec;177(12):1735-1743. doi: 10.1007/s00431-018-3238-3. Epub 2018 Sep 7.

PMID:
30194525
6.

Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms.

Vears DF, Niemiec E, Howard HC, Borry P.

Eur J Hum Genet. 2018 Dec;26(12):1743-1751. doi: 10.1038/s41431-018-0239-7. Epub 2018 Aug 24.

PMID:
30143804
7.

How do consent forms for diagnostic high-throughput sequencing address unsolicited and secondary findings? A content analysis.

Vears DF, Niemiec E, Howard HC, Borry P.

Clin Genet. 2018 Oct;94(3-4):321-329. doi: 10.1111/cge.13391. Epub 2018 Jul 8.

PMID:
29888485
8.

Participants' decision to enroll in cohort studies with biobanks: quantitative insights from two German studies.

Nobile H, Borry P, Pischon T, Steinbrecher A, Boeing H, Vigl M, Bergmann MM.

Per Med. 2017 Nov;14(6):477-485. doi: 10.2217/pme-2017-0049. Epub 2017 Nov 24.

PMID:
29749857
9.

Noninvasive prenatal testing: a survey of young (future) parents in Flanders.

Borry P, Favaretto M, Batthyany A, Boey E, Van Tongerloo S, Dooms M, Huys I.

Per Med. 2018 Jan;15(1):35-43. doi: 10.2217/pme-2017-0065.

PMID:
29714113
10.

Forensic Epigenetic Age Estimation and Beyond: Ethical and Legal Considerations.

Shabani M, Borry P, Smeers I, Bekaert B.

Trends Genet. 2018 Jul;34(7):489-491. doi: 10.1016/j.tig.2018.03.006. Epub 2018 Apr 16.

PMID:
29674182
11.

The author who wasn't there? Fairness and attribution in publications following access to population biobanks.

Kleiderman E, Pack A, Borry P, Zawati M.

PLoS One. 2018 Mar 23;13(3):e0194997. doi: 10.1371/journal.pone.0194997. eCollection 2018.

12.

Do athletes have a right to access data in their Athlete Biological Passport?

Devriendt T, Chokoshvili D, Favaretto M, Borry P.

Drug Test Anal. 2018 May;10(5):802-806. doi: 10.1002/dta.2380. Epub 2018 Apr 20. Review.

PMID:
29524351
13.

Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel.

Borry P, Caulfield T, Estivill X, Loland S, McNamee M, Knoppers BM; WADA Ethics Panel.

Br J Sports Med. 2018 Apr;52(7):456-459. doi: 10.1136/bjsports-2017-098299. Epub 2018 Mar 2.

14.

A systematic analysis of online marketing materials used by providers of expanded carrier screening.

Chokoshvili D, Borry P, Vears DF.

Genet Med. 2018 Sep;20(9):976-984. doi: 10.1038/gim.2017.222. Epub 2017 Dec 14.

PMID:
29240075
15.

Recent developments in genetics and medically assisted reproduction: from research to clinical applications.

Harper JC, Aittomäki K, Borry P, Cornel MC, de Wert G, Dondorp W, Geraedts J, Gianaroli L, Ketterson K, Liebaers I, Lundin K, Mertes H, Morris M, Pennings G, Sermon K, Spits C, Soini S, van Montfoort APA, Veiga A, Vermeesch JR, Viville S, Macek M Jr; on behalf of the European Society of Human Reproduction and Embryology and European Society of Human Genetics.

Eur J Hum Genet. 2018 Jan;26(1):12-33. doi: 10.1038/s41431-017-0016-z. Epub 2017 Dec 4. Review.

16.

One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans.

Howard HC, van El CG, Forzano F, Radojkovic D, Rial-Sebbag E, de Wert G, Borry P, Cornel MC; Public and Professional Policy Committee of the European Society of Human Genetics.

Eur J Hum Genet. 2018 Jan;26(1):1-11. doi: 10.1038/s41431-017-0024-z. Epub 2017 Nov 30.

17.

Rules for processing genetic data for research purposes in view of the new EU General Data Protection Regulation.

Shabani M, Borry P.

Eur J Hum Genet. 2018 Feb;26(2):149-156. doi: 10.1038/s41431-017-0045-7. Epub 2017 Nov 29. Review.

18.

Points to consider for laboratories reporting results from diagnostic genomic sequencing.

Vears DF, Sénécal K, Clarke AJ, Jackson L, Laberge AM, Lovrecic L, Piton A, Van Gassen KLI, Yntema HG, Knoppers BM, Borry P.

Eur J Hum Genet. 2018 Jan;26(1):36-43. doi: 10.1038/s41431-017-0043-9. Epub 2017 Nov 28.

19.

Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape.

Kalokairinou L, Howard HC, Slokenberga S, Fisher E, Flatscher-Thöni M, Hartlev M, van Hellemondt R, Juškevičius J, Kapelenska-Pregowska J, Kováč P, Lovrečić L, Nys H, de Paor A, Phillips A, Prudil L, Rial-Sebbag E, Romeo Casabona CM, Sándor J, Schuster A, Soini S, Søvig KH, Stoffel D, Titma T, Trokanas T, Borry P.

J Community Genet. 2018 Apr;9(2):117-132. doi: 10.1007/s12687-017-0344-2. Epub 2017 Nov 18.

20.

Research ethics review for the use of anonymized samples and data: A systematic review of normative documents.

Phillips A, Borry P, Shabani M.

Account Res. 2017;24(8):483-496. doi: 10.1080/08989621.2017.1396896. Review.

PMID:
29140743
21.

Raw Genomic Data: Storage, Access, and Sharing.

Shabani M, Vears D, Borry P.

Trends Genet. 2018 Jan;34(1):8-10. doi: 10.1016/j.tig.2017.10.004. Epub 2017 Nov 10.

PMID:
29132689
22.

Genuine participation in participant-centred research initiatives: the rhetoric and the potential reality.

Feeney O, Borry P, Felzmann H, Galvagni L, Haukkala A, Loi M, Nordal S, Rakic V, Riso B, Sterckx S, Vears D.

J Community Genet. 2018 Apr;9(2):133-142. doi: 10.1007/s12687-017-0342-4. Epub 2017 Oct 24.

23.

Responsible implementation of expanded carrier screening.

Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F, Hall A, Howard HC, Janssens S, Kayserili H, Lakeman P, Lucassen A, Metcalfe SA, Vidmar L, de Wert G, Dondorp WJ, Peterlin B.

Eur J Hum Genet. 2017 Nov;25(11):1291. doi: 10.1038/ejhg.2017.159.

24.

Time out: ethical reflections on medical disqualification of athletes in the context of mandated pre-participation cardiac screening.

Magavern EF, Finocchiaro G, Sharma S, Papadakis M, Borry P.

Br J Sports Med. 2018 Sep;52(18):1207-1210. doi: 10.1136/bjsports-2017-097524. Epub 2017 Oct 11. No abstract available.

PMID:
29021245
25.

Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.

De Rechter S, Kringen J, Janssens P, Liebau MC, Devriendt K, Levtchenko E, Bergmann C, Jouret F, Bammens B, Borry P, Schaefer F, Mekahli D.

PLoS One. 2017 Sep 29;12(9):e0185779. doi: 10.1371/journal.pone.0185779. eCollection 2017.

26.

The challenges of the expanded availability of genomic information: an agenda-setting paper.

Borry P, Bentzen HB, Budin-Ljøsne I, Cornel MC, Howard HC, Feeney O, Jackson L, Mascalzoni D, Mendes Á, Peterlin B, Riso B, Shabani M, Skirton H, Sterckx S, Vears D, Wjst M, Felzmann H.

J Community Genet. 2018 Apr;9(2):103-116. doi: 10.1007/s12687-017-0331-7. Epub 2017 Sep 26.

27.

Readability of informed consent forms for whole-exome and whole-genome sequencing.

Niemiec E, Vears DF, Borry P, Howard HC.

J Community Genet. 2018 Apr;9(2):143-151. doi: 10.1007/s12687-017-0324-6. Epub 2017 Aug 31.

28.

Oversight of Genomic Data Sharing: What Roles for Ethics and Data Access Committees?

Shabani M, Dove ES, Murtagh M, Knoppers BM, Borry P.

Biopreserv Biobank. 2017 Oct;15(5):469-474. doi: 10.1089/bio.2017.0045. Epub 2017 Aug 24. Review.

PMID:
28836815
29.

Third party interpretation of raw genetic data: an ethical exploration.

Badalato L, Kalokairinou L, Borry P.

Eur J Hum Genet. 2017 Nov;25(11):1189-1194. doi: 10.1038/ejhg.2017.126. Epub 2017 Aug 23. Review.

30.

Reporting practices for variants of uncertain significance from next generation sequencing technologies.

Vears DF, Sénécal K, Borry P.

Eur J Med Genet. 2017 Oct;60(10):553-558. doi: 10.1016/j.ejmg.2017.07.016. Epub 2017 Aug 1.

PMID:
28774848
31.

Pre- and post-testing counseling considerations for the provision of expanded carrier screening: exploration of European geneticists' views.

Janssens S, Chokoshvili D, Vears DF, De Paepe A, Borry P.

BMC Med Ethics. 2017 Aug 1;18(1):46. doi: 10.1186/s12910-017-0206-9.

32.

Regulating the advertising of genetic tests in Europe: a balancing act.

Kalokairinou L, Borry P, Howard HC.

J Med Genet. 2017 Oct;54(10):651-656. doi: 10.1136/jmedgenet-2017-104531. Epub 2017 Jul 22.

PMID:
28735297
33.

Expanded carrier screening for monogenic disorders: where are we now?

Chokoshvili D, Vears D, Borry P.

Prenat Diagn. 2018 Jan;38(1):59-66. doi: 10.1002/pd.5109. Epub 2017 Jul 27. Review.

PMID:
28685505
34.

Newspaper coverage of human-pig chimera research: A qualitative study on select media coverage of scientific breakthrough.

Hagan-Brown A, Favaretto M, Borry P.

Xenotransplantation. 2017 Jul;24(4). doi: 10.1111/xen.12317. Epub 2017 Jul 5.

PMID:
28677148
35.

Reply to C Harling.

Sénécal K, Thys K, Vears DF, Van Assche K, Knoppers BM, Borry P.

Eur J Hum Genet. 2017 Sep;25(9):1030. doi: 10.1038/ejhg.2017.89. Epub 2017 May 31. No abstract available.

36.

Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel.

Vears DF, Sénécal K, Borry P.

Hum Mutat. 2017 Aug;38(8):905-911. doi: 10.1002/humu.23259. Epub 2017 Jun 6.

PMID:
28512758
37.

Legal approaches regarding health-care decisions involving minors: implications for next-generation sequencing.

Sénécal K, Thys K, Vears DF, Van Assche K, Knoppers BM, Borry P.

Eur J Hum Genet. 2017 May;25(5):658. doi: 10.1038/ejhg.2017.41. No abstract available.

38.

Public Views on Genetics and Genetic Testing: A Survey of the General Public in Belgium.

Chokoshvili D, Belmans C, Poncelet R, Sanders S, Vaes D, Vears D, Janssens S, Huys I, Borry P.

Genet Test Mol Biomarkers. 2017 Mar;21(3):195-201. doi: 10.1089/gtmb.2016.0418.

39.

Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.

Chokoshvili D, Vears DF, Borry P.

Best Pract Res Clin Obstet Gynaecol. 2017 Oct;44:57-67. doi: 10.1016/j.bpobgyn.2017.02.006. Epub 2017 Feb 16. Review.

PMID:
28302443
40.

Paternity testing under the cloak of recreational genetics.

Moray N, Pink KE, Borry P, Larmuseau MH.

Eur J Hum Genet. 2017 Jun;25(6):768-770. doi: 10.1038/ejhg.2017.31. Epub 2017 Mar 8.

41.

Unsolved challenges in pediatric whole-exome sequencing: A literature analysis.

Bertier G, Sénécal K, Borry P, Vears DF.

Crit Rev Clin Lab Sci. 2017 Mar;54(2):134-142. doi: 10.1080/10408363.2016.1275516. Epub 2017 Jan 28. Review.

PMID:
28132577
42.

Reply to Kranendonk et al.

Sénécal K, Thys K, Vears DF, Van Assche K, Knoppers BM, Borry P.

Eur J Hum Genet. 2017 Feb;25(2):166-167. doi: 10.1038/ejhg.2016.160. Epub 2016 Nov 23. No abstract available.

43.

Attitudes of European Geneticists Regarding Expanded Carrier Screening.

Janssens S, Chokoshvili D, Vears D, De Paepe A, Borry P.

J Obstet Gynecol Neonatal Nurs. 2017 Jan - Feb;46(1):63-71. doi: 10.1016/j.jogn.2016.08.012. Epub 2016 Nov 19.

PMID:
27875676
44.

Recontacting Pediatric Research Participants for Consent When They Reach the Age of Majority.

Knoppers BM, Sénécal K, Boisjoli J, Borry P, Cornel MC, Fernandez CV, Grewal J, Holm IA, Nelson E, Pinxten W, Shabani M, Tassé AM, Zawati M, Clayton W.

IRB. 2016 Nov-Dec;38(6):1-9.

PMID:
30088377
45.

Designing expanded carrier screening panels: results of a qualitative study with European geneticists.

Chokoshvili D, Janssens S, Vears D, Borry P.

Per Med. 2016 Nov;13(6):553-562. doi: 10.2217/pme-2016-0018. Epub 2016 Oct 13.

PMID:
29754544
46.

Marginally scientific? Genetic testing of children and adolescents for lifestyle and health promotion.

Caulfield T, Borry P, Toews M, Elger BS, Greely HT, McGuire A.

J Law Biosci. 2015 Nov 16;2(3):627-644. eCollection 2015 Nov. No abstract available.

47.

Ethical considerations for genetic testing in the context of mandated cardiac screening before athletic participation.

Magavern EF, Badalato L, Finocchiaro G, Borry P.

Genet Med. 2017 May;19(5):493-495. doi: 10.1038/gim.2016.146. Epub 2016 Sep 22. No abstract available.

PMID:
27657677
48.

Participation of Children in Medical Decision-Making: Challenges and Potential Solutions.

Jeremic V, Sénécal K, Borry P, Chokoshvili D, Vears DF.

J Bioeth Inq. 2016 Dec;13(4):525-534. doi: 10.1007/s11673-016-9747-8. Epub 2016 Sep 21.

PMID:
27654498
49.

Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies.

Niemiec E, Borry P, Pinxten W, Howard HC.

Hum Mutat. 2016 Dec;37(12):1248-1256. doi: 10.1002/humu.23122. Epub 2016 Oct 5.

PMID:
27647801
50.

Who should have access to genomic data and how should they be held accountable? Perspectives of Data Access Committee members and experts.

Shabani M, Thorogood A, Borry P.

Eur J Hum Genet. 2016 Dec;24(12):1671-1675. doi: 10.1038/ejhg.2016.111. Epub 2016 Aug 24.

Supplemental Content

Support Center